Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-04-27 @ 8:41 AM
Study NCT ID:
NCT05683457
Status:
RECRUITING
Last Update Posted:
2025-03-13
First Post:
2023-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
Sponsor:
ModernaTX, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cytomegalovirus Infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Human cytomegalovirus | View |
| None | Human Herpesvirus | View |
| None | mRNA-1647 | View |
| None | Moderna | View |
| None | CMV | View |
| None | Cytomegalovirus Vaccine | View |
| None | Cytomegalovirus Infections | View |
| None | Cytomegalovirus Congenital | View |
| None | Virus Disease | View |
| None | Infection Viral | View |
| None | DNA Virus Infections | View |
| None | Messenger RNA | View |
| None | Hematopoietic cell transplantation | View |